Document is current

Article History

Received: 19 November 2024

Accepted: 12 March 2025

First Online: 19 March 2025

Declaration

:

: The authors declare no competing interests.

: The study was submitted for review and received approval from the Hospital Ethics Committee: [2023] Lun Shen Zi (LW-96). The committee conducted a comprehensive evaluation of the study protocol, informed consent form, data collection, and analysis methods to ensure compliance with ethical standards and regulations. Strict measures will be in place to protect participants’ personal information and research data, ensuring that these are not disclosed to unauthorized third parties. Study Risks: While the study aims to evaluate the safety and efficacy of 3D-printed wig protection devices, certain risks may arise. The investigators will closely monitor participants’ health and intervene as necessary to safeguard their well-being. Use and Release of Study Results: The investigators ensure that the study results will be used and released ethically, avoiding any misleading conclusions or harm to participants’ rights and interests. For detailed research steps, refer to the Research Protocol and the Chinese Clinical Trial Registry link .

: It involves details about the study’s purpose, methods, risks, potential benefits, participants’ rights, data confidentiality measures, and the right to withdraw from the study. The investigator provides a thorough explanation of the study and the consent form to potential participants and their families to ensure they fully understand the study and voluntarily sign the consent form.